Company Number: 14305798

Analysis Date: 2025-07-20 17:27 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   ARUNS PHARM LTD is a recently incorporated micro-entity operating as a dispensing chemist. The company shows some fixed assets (£350k) and a positive net asset position (£9,288) as of 31 March 2024. However, the balance sheet is heavily leveraged with significant long-term creditors (£356,603) just offsetting fixed assets, resulting in very thin equity. Net current assets are positive but modest (£15,938). Given the company's short trading history (incorporated Aug 2022) and limited financial track record, credit exposure should be cautiously limited and monitored closely. Approval should be conditional on updated management accounts and evidence of sustainable cash generation before increasing credit lines.

2. Financial Strength:
   The balance sheet reflects initial capital investment largely in fixed assets, likely pharmacy equipment or premises fit-out. Current assets (£131,708) provide some working capital buffer, but current liabilities of £115,770 indicate near break-even short-term liquidity. The long-term creditor balance (£356,603) is substantial relative to net assets, suggesting reliance on external financing or vendor credit. Shareholders' funds are minimal (£9,288), indicating low equity buffer against liabilities. Overall, the company’s financial structure is fragile with high leverage and limited accumulated retained earnings, typical of a start-up phase.

3. Cash Flow Assessment:
   While exact cash flow data is not provided, the positive net current assets suggest the company can meet short-term obligations. The increase in employees (7 average in 2024 vs zero prior year) indicates growth in operational activity, which requires close cash flow management. The company must ensure receivables collection and inventory turnover remain efficient to avoid liquidity strain. Reliance on long-term creditors highlights the importance of maintaining creditor support and generating sufficient operating cash flow to service debt and fund working capital.

4. Monitoring Points:

• Quarterly management accounts to track revenue growth and cash flow trends
• Working capital ratios, especially current ratio and quick ratio
• Debt servicing capacity and creditor payment terms adherence
• Profitability progression to build retained earnings and equity buffer
• Any changes in ownership or director management impacting financial controls or strategy